Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03029962 · ClinicalTrials.gov registry record · NA
Girl2Girl: Harnessing Text Messaging to Reduce Teenage Pregnancy Among LGB Girls
A NA study, sponsored by Center for Innovative Public Health Research.
- Completed
- Registry status
- NA
- Development phase
- 948
- Enrollment target
NCT03029962: Completed NA study, sponsored by Center for Innovative Public Health Research.
NCT03029962 is a NA study that has completed, run by Center for Innovative Public Health Research. The registered enrollment target is 948 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (32% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03029962, a NA study, has completed, sponsored by Center for Innovative Public Health Research.
- COMPLETED
- Registry status
- NA
- Development phase
- 948 participants
- Enrollment target
Study Summary
The purpose of this study is to finalize and rigorously evaluate Girl2Girl, a novel text messaging-based teenage pregnancy prevention (TPP) program designed specifically for LGB women ages 14-18 years, nation-wide. The guiding theoretical model is the Information-Motivation-Behavioral Skills (IMB) Model, which has been used extensively and is associated with increases in TPP behavior.
Primary Outcome
The relative difference of protected penile-vaginal sex acts in the intervention versus control group at 12-months post-intervention
Interventions
- BEHAVIORAL Girl2Girl
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 948 participants |
| Start Date | 2016-10 |
| Est. Completion | 2020-01-12 |
| Phase | NA |
What the finished NCT03029962 record still lists
NCT03029962 is an interventional study that assigns participants to a tested intervention. The registered 948 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (32% lower).
The record links to 0 conditions, and to 1 intervention - of which Girl2Girl is the first listed.
NCT03029962 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03029962 about?
NCT03029962 is a clinical study titled "Girl2Girl: Harnessing Text Messaging to Reduce Teenage Pregnancy Among LGB Girls". The purpose of this study is to finalize and rigorously evaluate Girl2Girl, a novel text messaging-based teenage pregnancy prevention (TPP) program designed specifically for LGB women ages 14-18 years, nation-wide. The guiding theoretical model is the Information-Motivation-Behavioral Skills (IMB) M...
What is the current status of trial NCT03029962?
This trial is currently completed. It is a NA study. The enrollment target is 948 participants. The study started on 2016-10. Estimated completion is 2020-01-12.
What interventions are being tested in trial NCT03029962?
The interventions under investigation include: Girl2Girl (BEHAVIORAL).
Who is sponsoring clinical trial NCT03029962?
This trial is sponsored by Center for Innovative Public Health Research, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03029962's enrollment target sits among peer trials
948 123rd of 2000 higher than 1,878 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04895709 · 949 participants · Phase 1
A Study of BMS-986340 as Monotherapy and in Combination With Nivolumab or Docetaxel in Participants With Advanced Solid Tumors
- NCT06087224 · 947 participants · NA
The TELENEO Trial: A Multicenter Trial of Telemedicine for Advanced Neonatal Resuscitations in Community Hospitals
- NCT03784924 · 950 participants
EDRN Prostate MRI Biomarker Study
- NCT04180930 · 950 participants
An Evaluation of Two PTSD Assessments in an Active Duty and Military Veteran Sample
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia